0001127602-12-020259.txt : 20120618
0001127602-12-020259.hdr.sgml : 20120618
20120618165448
ACCESSION NUMBER: 0001127602-12-020259
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120618
FILED AS OF DATE: 20120618
DATE AS OF CHANGE: 20120618
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROTHBLATT MARTINE A
CENTRAL INDEX KEY: 0001106578
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-26301
FILM NUMBER: 12912924
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp
CENTRAL INDEX KEY: 0001082554
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 521984749
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
BUSINESS PHONE: 3016089292
MAIL ADDRESS:
STREET 1: 1040 SPRING ST
CITY: SILVER SPRING
STATE: MD
ZIP: 20910
FORMER COMPANY:
FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP
DATE OF NAME CHANGE: 19990324
4
1
form4.xml
PRIMARY DOCUMENT
X0305
4
2012-06-18
0001082554
UNITED THERAPEUTICS Corp
UTHR
0001106578
ROTHBLATT MARTINE A
C/O UNITED THERAPEUTICS CORPORATION
1040 SPRING STREET
SILVER SPRING
MD
20910
1
1
CEO
Common Stock
2012-06-18
2012-06-18
4
P
0
4130
47.9964
A
682504
I
By Trusts
Common Stock
0
D
This transaction was executed in multiple trades at prices ranging from $47.50 to $48.25. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Shares were purchased pursuant to a pre-arranged 10b5-1 trading plan entered into by a Grantor Retained Annuity Trust beneficially owned by the reporting person and the reporting person's spouse.
Shares held by the reporting person in GRATs and PMTs.
/s/ John S. Hess, Jr. under Power of Attorney
2012-06-18